APO Research

APO RESEARCH · REPORT

Olanzapine Orally Disintegrating Tablets

Selected research

Market Structure

Global Olanzapine Orally Disintegrating Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Olanzapine Orally Disintegrating Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Olanzapine Orally Disintegrating Tablets include Apotex, Dr. Reddy's Laboratories, PKU HealthCare, QILU Pharmaceutical, Sunshine Lake Pharma, Torrent Pharmaceuticals, Eli Lilly Nederland B.V., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Olanzapine Orally Disintegrating Tablets market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Olanzapine Orally Disintegrating Tablets and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Olanzapine Orally Disintegrating Tablets revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Olanzapine Orally Disintegrating Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Olanzapine Orally Disintegrating Tablets Segment by Company

Apotex

Dr. Reddy's Laboratories

PKU HealthCare

QILU Pharmaceutical

Sunshine Lake Pharma

Torrent Pharmaceuticals

Eli Lilly Nederland B.V.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical

Chengdu Easton Biopharmaceuticals

Olanzapine Orally Disintegrating Tablets Segment by Type

5mg

20mg

15mg

10mg

Olanzapine Orally Disintegrating Tablets Segment by Application

Hospital

Clinic

Others

Olanzapine Orally Disintegrating Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine Orally Disintegrating Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olanzapine Orally Disintegrating Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine Orally Disintegrating Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Olanzapine Orally Disintegrating Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Olanzapine Orally Disintegrating Tablets industry.

Chapter 3: Detailed analysis of Olanzapine Orally Disintegrating Tablets companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Olanzapine Orally Disintegrating Tabletsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 5mg Table 3. Key Players of 20mg Table 4. Key Players of 15mg Table 3. Key Players of 10mg Table 4. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Others Table 8. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Olanzapine Orally Disintegrating Tablets Market Share by Region (2021-2026) Table 11. Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Olanzapine Orally Disintegrating Tablets Market Share by Region (2027-2032) Table 13. Olanzapine Orally Disintegrating Tablets Industry Trends Table 14. Olanzapine Orally Disintegrating Tablets Industry Drivers Table 15. Olanzapine Orally Disintegrating Tablets Industry Opportunities and Challenges Table 16. Olanzapine Orally Disintegrating Tablets Industry Restraints Table 17. Global Olanzapine Orally Disintegrating Tablets Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Company (2021-2026) Table 19. Global Olanzapine Orally Disintegrating Tablets Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Olanzapine Orally Disintegrating Tablets Key Company Head Office and Area Served Table 21. Global Olanzapine Orally Disintegrating Tablets Company, Product Type & Application Table 22. Global Olanzapine Orally Disintegrating Tablets Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Olanzapine Orally Disintegrating Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Olanzapine Orally Disintegrating Tablets Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Type (2021-2026) Table 29. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Type (2027-2032) Table 30. Global Olanzapine Orally Disintegrating Tablets Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2021-2026) Table 34. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2027-2032) Table 35. Apotex Company Information Table 36. Apotex Business Overview Table 37. Apotex Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio Table 39. Apotex Recent Development Table 40. Dr. Reddy's Laboratories Company Information Table 41. Dr. Reddy's Laboratories Business Overview Table 42. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio Table 44. Dr. Reddy's Laboratories Recent Development Table 45. PKU HealthCare Company Information Table 46. PKU HealthCare Business Overview Table 47. PKU HealthCare Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio Table 49. PKU HealthCare Recent Development Table 50. QILU Pharmaceutical Company Information Table 51. QILU Pharmaceutical Business Overview Table 52. QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio Table 54. QILU Pharmaceutical Recent Development Table 55. Sunshine Lake Pharma Company Information Table 56. Sunshine Lake Pharma Business Overview Table 57. Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio Table 59. Sunshine Lake Pharma Recent Development Table 60. Torrent Pharmaceuticals Company Information Table 61. Torrent Pharmaceuticals Business Overview Table 62. Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio Table 64. Torrent Pharmaceuticals Recent Development Table 65. Eli Lilly Nederland B.V. Company Information Table 66. Eli Lilly Nederland B.V. Business Overview Table 67. Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio Table 69. Eli Lilly Nederland B.V. Recent Development Table 70. Sun Pharmaceutical Industries Ltd. Company Information Table 71. Sun Pharmaceutical Industries Ltd. Business Overview Table 72. Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio Table 74. Sun Pharmaceutical Industries Ltd. Recent Development Table 75. Teva Pharmaceutical Company Information Table 76. Teva Pharmaceutical Business Overview Table 77. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio Table 79. Teva Pharmaceutical Recent Development Table 80. Chengdu Easton Biopharmaceuticals Company Information Table 81. Chengdu Easton Biopharmaceuticals Business Overview Table 82. Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio Table 84. Chengdu Easton Biopharmaceuticals Recent Development Table 85. North America Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) Table 91. North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032) Table 92. Europe Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) Table 98. Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032) Table 99. China Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026) & (US$ Million) Table 100. China Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032) & (US$ Million) Table 101. China Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026) & (US$ Million) Table 102. China Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) Table 109. Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Olanzapine Orally Disintegrating Tablets Product Image Figure 2. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Olanzapine Orally Disintegrating Tablets Market Share by Type: 2025 VS 2032 Figure 4. 5mg Image Figure 5. 20mg Image Figure 6. 15mg Image Figure 7. 10mg Image Figure 8. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Olanzapine Orally Disintegrating Tablets Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Olanzapine Orally Disintegrating Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 15. Global Olanzapine Orally Disintegrating Tablets Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Olanzapine Orally Disintegrating Tablets Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Olanzapine Orally Disintegrating Tablets Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Type (2021-2032) Figure 22. Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 25. North America Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032) Figure 26. North America Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032) Figure 27. North America Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 28. United States Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 29. Canada Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 31. Europe Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 32. Europe Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032) Figure 33. Europe Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032) Figure 34. Europe Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 35. Germany Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 36. France Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 38. Italy Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 39. Russia Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 41. China Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 42. China Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032) Figure 43. China Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032) Figure 44. Asia Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 45. Asia Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032) Figure 46. Asia Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032) Figure 47. Asia Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 48. Japan Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 52. India Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 53. Australia Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032) Figure 58. Brazil Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 63. UAE Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 65. Chile Olanzapine Orally Disintegrating Tablets Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 20mg
  • 15mg
  • 10mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Apotex
  • Dr. Reddy's Laboratories
  • PKU HealthCare
  • QILU Pharmaceutical
  • Sunshine Lake Pharma
  • Torrent Pharmaceuticals
  • Eli Lilly Nederland B.V.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical
  • Chengdu Easton Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 5mg
  5. 1.2.3 20mg
  6. 1.2.4 15mg
  7. 1.2.5 10mg
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Olanzapine Orally Disintegrating Tablets Growth Trends by Region
  15. 1.5.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2026)
  17. 1.5.3 Olanzapine Orally Disintegrating Tablets Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Olanzapine Orally Disintegrating Tablets Market Dynamics
  1. 2.1 Olanzapine Orally Disintegrating Tablets Industry Trends
  2. 2.2 Olanzapine Orally Disintegrating Tablets Industry Drivers
  3. 2.3 Olanzapine Orally Disintegrating Tablets Industry Opportunities and Challenges
  4. 2.4 Olanzapine Orally Disintegrating Tablets Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Olanzapine Orally Disintegrating Tablets Revenue by Company (2021-2026)
  2. 3.2 Global Olanzapine Orally Disintegrating Tablets Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Olanzapine Orally Disintegrating Tablets Key Company Head office and Area Served
  4. 3.4 Global Olanzapine Orally Disintegrating Tablets Company, Product Type & Application
  5. 3.5 Global Olanzapine Orally Disintegrating Tablets Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Olanzapine Orally Disintegrating Tablets Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Olanzapine Orally Disintegrating Tablets Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Olanzapine Orally Disintegrating Tablets Tier 1, Tier 2, and Tier 3
4 Olanzapine Orally Disintegrating Tablets Market by Type
  1. 4.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2032)
  3. 4.3 Global Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2032)
5 Olanzapine Orally Disintegrating Tablets Market by Application
  1. 5.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2032)
  3. 5.3 Global Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Apotex
  2. 6.1.1 Apotex Company Information
  3. 6.1.2 Apotex Business Overview
  4. 6.1.3 Apotex Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio
  6. 6.1.5 Apotex Recent Developments
  7. 6.2 Dr. Reddy's Laboratories
  8. 6.2.1 Dr. Reddy's Laboratories Company Information
  9. 6.2.2 Dr. Reddy's Laboratories Business Overview
  10. 6.2.3 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio
  12. 6.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 6.3 PKU HealthCare
  14. 6.3.1 PKU HealthCare Company Information
  15. 6.3.2 PKU HealthCare Business Overview
  16. 6.3.3 PKU HealthCare Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio
  18. 6.3.5 PKU HealthCare Recent Developments
  19. 6.4 QILU Pharmaceutical
  20. 6.4.1 QILU Pharmaceutical Company Information
  21. 6.4.2 QILU Pharmaceutical Business Overview
  22. 6.4.3 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
  24. 6.4.5 QILU Pharmaceutical Recent Developments
  25. 6.5 Sunshine Lake Pharma
  26. 6.5.1 Sunshine Lake Pharma Company Information
  27. 6.5.2 Sunshine Lake Pharma Business Overview
  28. 6.5.3 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio
  30. 6.5.5 Sunshine Lake Pharma Recent Developments
  31. 6.6 Torrent Pharmaceuticals
  32. 6.6.1 Torrent Pharmaceuticals Company Information
  33. 6.6.2 Torrent Pharmaceuticals Business Overview
  34. 6.6.3 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
  36. 6.6.5 Torrent Pharmaceuticals Recent Developments
  37. 6.7 Eli Lilly Nederland B.V.
  38. 6.7.1 Eli Lilly Nederland B.V. Company Information
  39. 6.7.2 Eli Lilly Nederland B.V. Business Overview
  40. 6.7.3 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio
  42. 6.7.5 Eli Lilly Nederland B.V. Recent Developments
  43. 6.8 Sun Pharmaceutical Industries Ltd.
  44. 6.8.1 Sun Pharmaceutical Industries Ltd. Company Information
  45. 6.8.2 Sun Pharmaceutical Industries Ltd. Business Overview
  46. 6.8.3 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 Chengdu Easton Biopharmaceuticals
  56. 6.10.1 Chengdu Easton Biopharmaceuticals Company Information
  57. 6.10.2 Chengdu Easton Biopharmaceuticals Business Overview
  58. 6.10.3 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
  60. 6.10.5 Chengdu Easton Biopharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
  2. 7.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Type
  3. 7.2.1 North America Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
  4. 7.2.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
  5. 7.2.3 North America Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
  6. 7.3 North America Olanzapine Orally Disintegrating Tablets Market Size by Application
  7. 7.3.1 North America Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
  8. 7.3.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
  9. 7.3.3 North America Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
  10. 7.4 North America Olanzapine Orally Disintegrating Tablets Market Size by Country
  11. 7.4.1 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  13. 7.4.3 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
  14. 7.4.4 North America Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
  2. 8.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Type
  3. 8.2.1 Europe Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
  4. 8.2.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
  5. 8.2.3 Europe Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
  6. 8.3 Europe Olanzapine Orally Disintegrating Tablets Market Size by Application
  7. 8.3.1 Europe Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
  8. 8.3.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
  9. 8.3.3 Europe Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
  10. 8.4 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country
  11. 8.4.1 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  13. 8.4.3 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
  14. 8.4.4 Europe Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
  2. 9.2 China Olanzapine Orally Disintegrating Tablets Market Size by Type
  3. 9.2.1 China Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
  4. 9.2.2 China Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
  5. 9.2.3 China Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
  6. 9.3 China Olanzapine Orally Disintegrating Tablets Market Size by Application
  7. 9.3.1 China Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
  8. 9.3.2 China Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
  9. 9.3.3 China Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
  2. 10.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Type
  3. 10.2.1 Asia Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
  4. 10.2.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
  5. 10.2.3 Asia Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
  6. 10.3 Asia Olanzapine Orally Disintegrating Tablets Market Size by Application
  7. 10.3.1 Asia Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
  8. 10.3.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
  9. 10.3.3 Asia Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
  10. 10.4 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country
  11. 10.4.1 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  13. 10.4.3 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
  14. 10.4.4 Asia Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research